A media briefing hosted by the Infectious Diseases Society of America to discuss tecovirimat (TPOXX) randomized controlled trials.
- Current state of monkeypox outbreak
- Clinical trial enrollment and outreach
- Questions from media
FEATURING:
Demetre C. Daskalakis, MD, MPH – White House Monkeypox National Response Team
White House National Monkeypox Response Deputy Coordinator
Director, Division of HIV Prevention, Centers for Disease Control and Prevention
Carl W. Dieffenbach, PhD – National Institute of Allergy and Infectious Diseases
Director, Division of AIDS, National Institute of Allergy and Infectious Diseases
Timothy Wilkin, MD, MPH – Weill Cornell Medicine
Infectious Disease Specialist, Weill Cornell Medicine
Investigator, Cornell Clinical Trials Unit
Amanda Jezek (Moderator)
Senior Vice President, Public Policy and Government Relations—Infectious Diseases Society of America
